Home › NDC Lookup › RxCUI directory › RxCUI 238129

1 ML buprenorphine 0.3 MG/ML Injection — RxCUI 238129

Name: 1 ML buprenorphine 0.3 MG/ML Injection (RxCUI 238129)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 238129 Semantic clinical drug · SCD ● Current RxNorm concept 3 FDA products 3 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI238129

Official name1 ML buprenorphine 0.3 MG/ML Injection

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asbuprenorphine HCl 0.3 MG per 1 ML Injection; buprenorphine HCl 0.3 MG in 1 ML Injection; buprenorphine 0.3 MG/ML (as buprenorphine HCl 0.324 MG/ML) Injection

FDA products mapped3

Package NDCs mapped3

Reported Medicaid activity (SDUD)384 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Buprenorphine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

No, the buprenorphine transdermal patch is specifically for managing severe, persistent pain that needs continuous, around-the-clock treatment over an extended period. It's prescri...
What is this patch actually for — is it for addiction treatment?
Each patch is worn on your skin for 7 days before being swapped out. You apply it to clean, dry, intact skin on your upper outer arm, upper chest, upper back, or side of the chest....
How do I apply the patch, and how long does each one last?

📖 Read our full Buprenorphine Transdermal Patch guide →

🕸️ Concept Web — How 1 ML buprenorphine 0.3 MG/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept 1 ML buprenorphine 0.3 MG/ML Injection RxCUI 238129 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 1

The active substance itself — no strength, form, or brand attached yet.
- Buprenorphine 1819 IN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Buprenex 203840 BN
Dose forms 6

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Buprenorphine Injection 1729358 SCDF
- Buprenorphine Injectable Product 1151361 SCDG
- Buprenorphine Injection [Buprenex] 1729360 SBDF
- Buprenex Injectable Product 1168687 SBDG
- Injection 1649574 DF
- Injectable Product 1151126 DFG
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Buprenorphine 0.3 MG/ML 330801 SCDC
- 1 ML buprenorphine 0.3 MG/ML Injection [Buprenex] 205533 SBD
- Buprenorphine 0.3 MG/ML [Buprenex] 566435 SBDC

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Buprenorphine 0.3 MG/ML SCDC · 330801
Buprenorphine Injection SCDF · 1729358
Buprenorphine Injectable Product SCDG · 1151361

Brand-Name Concepts

1 ML buprenorphine 0.3 MG/ML Injection [Buprenex] SBD · 205533
Buprenorphine 0.3 MG/ML [Buprenex] SBDC · 566435
Buprenorphine Injection [Buprenex] SBDF · 1729360
Buprenex Injectable Product SBDG · 1168687
Buprenex BN · 203840

📦 FDA Products & Package NDCs

3 products · 3 package NDCs

3 package NDCs map to RxCUI 238129 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00143-9246-05	5 VIAL in 1 CARTON (0143-9246-05) / 1 mL in 1 VIAL (0143-92...	Buprenorphine Hydrochloride	Hikma Pharmaceuticals USA Inc.	2019-07-12
42023-0179-05	5 VIAL in 1 CARTON (42023-179-05) / 1 mL in 1 VIAL	Buprenorphine Hydrochloride	Par Health USA, LLC	2015-07-30
70069-0027-05	5 VIAL in 1 CARTON (70069-027-05) / 1 mL in 1 VIAL	Buprenorphine Hydrochloride	Somerset Therapeutics, LLC	2025-02-11

Observed labelers: Hikma Pharmaceuticals USA Inc. (1) · Par Health USA, LLC (1) · Somerset Therapeutics, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J0592	Buprenorphine hydrochloride	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.